MIM
Martin Investment Management Portfolio holdings
AUM
$390M
This Quarter Return
-0.03%
1 Year Return
+9.2%
3 Year Return
+57.18%
5 Year Return
+97.51%
10 Year Return
+265.79%
AUM
$599M
AUM Growth
+$599M
(-6.5%)
Cap. Flow
-$39.3M
Cap. Flow
% of AUM
-6.55%
Top 10 Holdings %
Top 10 Hldgs %
38.81%
Holding
42
New
2
Increased
11
Reduced
27
Closed
2
Top Buys
| 1 |
CVS Health
CVS
|
$14M |
| 2 |
Check Point Software Technologies
CHKP
|
$4.57M |
| 3 |
Medtronic
MDT
|
$3.14M |
| 4 |
Chubb
CB
|
$2.75M |
| 5 |
NXP Semiconductors
NXPI
|
$2.53M |
Top Sells
| 1 |
Cencora
COR
|
$13.9M |
| 2 |
Thermo Fisher Scientific
TMO
|
$3.79M |
| 3 |
Abbott
ABT
|
$3.67M |
| 4 |
Stryker
SYK
|
$3.54M |
| 5 |
Fiserv
FI
|
$3.38M |
Sector Composition
| 1 | Healthcare | 22.92% |
| 2 | Technology | 21.97% |
| 3 | Financials | 19.64% |
| 4 | Industrials | 8.99% |
| 5 | Communication Services | 8.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Mastercard
MA
$538B
| $26.9M | 4.49% |
305,317
-32,365
| -10% | -$2.85M |
|
2
MSCI
MSCI
$43.9B
| $26.1M | 4.35% |
338,275
-36,346
| -10% | -$2.8M |
|
3
Apple
AAPL
$3.45T
| $25.6M | 4.27% |
267,546
-24,761
| -8% | -$2.37M |
|
|
4
Fiserv
FI
$75.1B
| $24.5M | 4.09% |
225,624
-31,043
| -12% | -$3.38M |
|
|
5
Stryker
SYK
$150B
| $22.6M | 3.77% |
188,353
-29,546
| -14% | -$3.54M |
|
6
Accenture
ACN
$162B
| $21.8M | 3.64% |
192,687
-1,189
| -0.6% | -$135K |
|
7
Berkshire Hathaway Class B
BRK.B
$1.09T
| $21.7M | 3.63% |
150,065
-14,240
| -9% | -$2.06M |
|
8
Booking.com
BKNG
$181B
| $21.3M | 3.55% |
17,051
-1,849
| -10% | -$2.31M |
|
|
CELG
9
DELISTED
Celgene Corp
CELG
| $21.3M | 3.55% |
215,491
-26,050
| -11% | -$2.57M |
|
|
10
Thermo Fisher Scientific
TMO
$186B
| $20.8M | 3.48% |
141,040
-25,667
| -15% | -$3.79M |
|
11
Omnicom Group
OMC
$15.2B
| $20.2M | 3.37% |
247,787
-20,905
| -8% | -$1.7M |
|
12
Colgate-Palmolive
CL
$67.9B
| $20M | 3.34% |
273,356
-25,018
| -8% | -$1.83M |
|
13
Exxon Mobil
XOM
$487B
| $19.8M | 3.3% |
210,771
-19,618
| -9% | -$1.84M |
|
14
Verisk Analytics
VRSK
$37.5B
| $19.8M | 3.3% |
243,616
-21,476
| -8% | -$1.74M |
|
15
Procter & Gamble
PG
$368B
| $19.7M | 3.29% |
233,160
-21,110
| -8% | -$1.79M |
|
16
Johnson & Johnson
JNJ
$427B
| $19.7M | 3.29% |
162,420
-23,747
| -13% | -$2.88M |
|
17
Gilead Sciences
GILD
$140B
| $19.5M | 3.26% |
234,218
-31,413
| -12% | -$2.62M |
|
18
3M
MMM
$82.8B
| $18.9M | 3.15% |
107,863
-5,512
| -5% | -$965K |
|
19
Travelers Companies
TRV
$61.1B
| $18.7M | 3.12% |
157,034
-4,368
| -3% | -$520K |
|
20
VF Corp
VFC
$5.91B
| $16.1M | 2.68% |
261,686
+3,869
| +2% | +$238K |
|
21
Alphabet (Google) Class A
GOOGL
$2.57T
| $16M | 2.66% |
22,694
-3,281
| -13% | -$2.31M |
|
22
Oracle
ORCL
$635B
| $15.8M | 2.63% |
385,797
-73,200
| -16% | -$3M |
|
23
RTX Corp
RTX
$212B
| $15.2M | 2.54% |
148,443
-8,428
| -5% | -$864K |
|
|
24
CVS Health
CVS
$92.8B
| $14M | 2.34% |
+146,601
| New | +$14M |
|
25
American Express
AXP
$231B
| $13.6M | 2.27% |
223,774
-13,589
| -6% | -$826K |
|